Relapse prevention among schizophrenia: A multi stage randomised controlled group study.

ISRCTN	ISRCTN20556456
DOI	https://doi.org/10.1186/ISRCTN20556456
Secondary identifying numbers	N0195129515

Submission date: 30/09/2004
Registration date: 30/09/2004
Last edited: 29/05/2012

Recruitment status: Stopped
Overall study status: Stopped
Condition category: Mental and Behavioural Disorders

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr Rami Jumnoodoo
Scientific

Trust
Park Royal MH Centre
Twyford Centre
Acton lane
Central Way
London
NW10 7NS
United Kingdom

Phone	+44 (0)208 453 2779
Email	rami.jumnoodoo@nhs.net

Study information

Study design	Randomised controlled trial
Primary study design	Interventional
Secondary study design	Randomised controlled trial
Study setting(s)	Other
Study type	Treatment
Participant information sheet	Not available in web format, please use the contact details below to request a patient information sheet
Scientific title
Study objectives	Whether a prescribed course of relapse prevention therapy (RPT), based on Marlatts model, may have a statistically significant higher knowledge score post-group; whether there will be a significant reduction of inpatient bed nights and whether there will be a statistically significant degree of contact maintenance with helping services by comparison with the comparison group?
Ethics approval(s)	Not provided at time of registration
Health condition(s) or problem(s) studied	Mental and Behavioural Disorders: Schizophrenia
Intervention	For the experimental group, there will be a semi structured interview questionnaire at pre and post relapse prevention therapy (RPT) and at 5 weeks follow up. For the control group, there will be a semi structured questionnaire to be completed at the same time as that of the experimental group and afterwards at 3 months interval to ensure matching time intervals. In addition there will be a demographic characteristic form to complete on ever participant.
Intervention type	Other
Primary outcome measure	Relapse prevention skills and knowledge, reduction of in-patient hospitalisation and an improvement in maintaining contact with helping services.
Secondary outcome measures	Not provided at time of registration
Overall study start date	08/07/2002
Completion date	16/06/2003
Reason abandoned (if study stopped)	Lack of staff/facilities/resources

Eligibility

Participant type(s)	Patient
Age group	Not Specified
Sex	Not Specified
Target number of participants	Not provided at time of registration
Key inclusion criteria	Patients with a primary diagnosis of schizophrenia (International Statistical Classification of Diseases and Related Health Problems - tenth revision [ICD10] = F20-29)
Key exclusion criteria	Does not meet inclusion criteria
Date of first enrolment	08/07/2002
Date of final enrolment	16/06/2003

Locations

Countries of recruitment

England
United Kingdom

Study participating centre

Trust

London
NW10 7NS
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website	http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Other

London West Mental R&D Consortium (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to share	No
IPD sharing plan summary	Not provided at time of registration
Publication and dissemination plan	Not provided at time of registration
IPD sharing plan